Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market
LOS ANGELES, Aug. 20, 2020 /PRNewswire/ — Science 37, the industry leader in decentralized clinical trials, today announced it closed an oversubscribed $40 million funding round. Existing investors Lux Capital, Redmile Group, and PPD, Inc. (Nasdaq: PPD) led the round, and are joined by…
Comments Off on Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market